| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 13,777 | 13,168 | 11,834 | 10,679 | | Cost of Revenue | 3,659 | 3,256 | 2,905 | 2,835 | | | Gross Profit | 10,118 | 9,912 | 8,929 | 7,844 | | | Operating Expenses | | Research Development | 1,630 | 1,469 | 1,355 | 1,352 | | Selling General and Administrative | 8,610 | 8,830 | 8,690 | 7,984 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (122) | (387) | (1,116) | (1,492) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 30 | 23 | 1 | 22 | | Earnings Before Interest And Taxes | (92) | (364) | (1,115) | (1,470) | | Interest Expense | 64 | 61 | 62 | 106 | | Income Before Tax | (156) | (425) | (1,177) | (1,576) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (156) | (425) | (1,177) | (1,576) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (156) | (425) | (1,177) | (1,576) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($156) | ($425) | ($1,177) | ($1,576) |
|
0.94% Nasdaq 
Income Statement
